AAAAAA
Results: 1-25/51
Authors:
PAESMANS M
Citation: M. Paesmans, STATISTICAL CONSIDERATIONS IN CLINICAL-TRIALS TESTING EMPIRIC ANTIBIOTIC REGIMENS IN PATIENTS WITH FEBRILE NEUTROPENIA, Supportive care in cancer, 6(5), 1998, pp. 438-443
Authors:
SCULIER JP
PAESMANS M
BUREAU G
RECLOUX P
BAUMOHL J
VANCUTSEM O
BERCHIER MC
THIRIAUX J
LAFITTE JJ
MOMMEN P
VANHOUTTE P
NINANE V
KLASTERSKY J
Citation: Jp. Sculier et al., A PHASE-III RANDOMIZED STUDY COMPARING, IN NON METASTATIC UNRESECTABLE NONSMALL CELL LUNG-CANCER (NSCLC) RESPONDING TO CHEMOTHERAPY (CT), FURTHER CT TO LOCO-REGIONAL IRRADIATION (RT), Annals of oncology, 9, 1998, pp. 399-399
Authors:
BAUMOHL J
SCULIER JP
PAESMANS M
BUREAU G
RECLOUX P
VANCUTSEM O
BERCHIER MC
THIRIAUX J
LAFITTE JJ
MOMMEN P
VANHOUTTE P
NINANE V
KLASTERSKY J
Citation: J. Baumohl et al., IS CHEMOSENSITIVITY A PREDICTIVE FACTOR FOR RADIOSENSITIVITY IN NONSMALL CELL LUNG-CANCER - LESSON FROM EUROPEAN LUNG-CANCER WORKING PARTY PHASE-III RANDOMIZED TRAIL, Annals of oncology, 9, 1998, pp. 402-402
Authors:
PAESMANS M
BERGHMANS T
LALAMI Y
LEMAITRE F
LOUVIAUX I
LUCE S
PEGRIMOCOVA R
VERMYLEN P
SCULIER JP
Citation: M. Paesmans et al., A LITERATURE-BASED QUALITATIVE AND QUANTITATIVE OVERVIEW OF CHEMOTHERAPY FOR MALIGNANT MESOTHELIOMA, Annals of oncology, 9, 1998, pp. 459-459
Authors:
LUCE S
PAESMANS M
BERGHMANS T
CASTAIGNE C
SOTIRIOU C
VERMYLEN P
SCULIER JP
Citation: S. Luce et al., CRITICAL-REVIEW OF THE RANDOMIZED TRIALS ASSESSING THE ROLE OF ADJUVANT THORACIC IRRADIATION IN LIMITED DISEASE SMALL-CELL LUNG-CANCER, Revue des maladies respiratoires, 15(5), 1998, pp. 633-641
Authors:
PAESMANS M
Citation: M. Paesmans, PROGNOSTIC FACTORS, Revue des maladies respiratoires, 15(3BIS), 1998, pp. 420-427
Authors:
SCULIER JP
PAESMANS M
THIRIAUX J
LECOMTE J
BUREAU G
GINER V
EFREMIDIS A
LAFITTE JJ
BERCHIER MC
ALEXOPOULOS CG
ZACHARIAS C
MOMMEN P
NINANE V
KLASTERSKY J
Citation: Jp. Sculier et al., PHASE-III RANDOMIZED TRIAL COMPARING CISPLATIN AND CARBOPLATIN WITH OR WITHOUT IFOSFAMIDE IN PATIENTS WITH ADVANCED NON-SMALL-CELL LUNG-CANCER, Journal of clinical oncology, 16(4), 1998, pp. 1388-1396
Authors:
SCULIER JP
BERGHMANS T
CASTAIGNE C
LUCE S
SOTIRIOU C
VERMYLEN P
PAESMANS M
Citation: Jp. Sculier et al., REPLY TO THE LETTER OF TRILLETLENOIR,V. ON SYSTEMATIC REVIEW ABOUT THE LITERATURE ON MAINTENANCE CHEMOTHERAPY IN SMALL-CELL LUNG-CANCER, Lung cancer, 21(3), 1998, pp. 225-226
Authors:
SCULIER JP
BERGHMANS T
CASTAIGNE C
LUCE S
SOTIRIOU C
VERMYLEN P
PAESMANS M
Citation: Jp. Sculier et al., MAINTENANCE CHEMOTHERAPY FOR SMALL-CELL LUNG-CANCER - A CRITICAL-REVIEW OF THE LITERATURE, Lung cancer, 19(2), 1998, pp. 141-151
Authors:
RAZAVI D
VANDECASTEELE H
PRIMO C
BODO M
DEBRIER F
VERBIST H
PAESMANS M
Citation: D. Razavi et al., IMPROVING CANCER PREVENTION AT THE WORKSITE - HOW ARE BELGIAN COMPANIES DEALING WITH SMOKING REGULATIONS, Psycho-oncology, 6(3), 1997, pp. 204-211
Authors:
BERGHMANS T
LUCE S
PAESMANS M
CASTAIGNE C
SOTIRIOU C
VERMYLEN P
SCULIER JP
Citation: T. Berghmans et al., RANDOMIZED TRIALS EVALUATING RADIOTHERAPY ADJUVANT TO CHEMOTHERAPY FOR SMALL-CELL LUNG-CARCINOMA (SCLC) - QUALITATIVE EVALUATION BEFORE METAANALYSIS, European journal of cancer, 33, 1997, pp. 1034-1034
Authors:
ANDRY G
PAESMANS M
ANDRYTHOOFT M
DELMELLE M
LARSIMONT D
LOTHAIRE P
VERHEST A
Citation: G. Andry et al., WELL-DIFFERENTIATED THYROID-CANCER - ANALYSIS OF SURVIVAL FOR 299 OPERATED PATIENTS, European journal of cancer, 33, 1997, pp. 1233-1233
Authors:
PAESMANS M
SCULIER JP
LIBERT P
BUREAU G
DABOUIS G
THIRIAUX J
MICHEL J
VANCUTSEM O
SERGYSELS R
MOMMEN P
KLASTERSKY J
Citation: M. Paesmans et al., RESPONSE TO CHEMOTHERAPY HAS PREDICTIVE VALUE FOR FURTHER SURVIVAL OFPATIENTS WITH ADVANCED NONSMALL CELL LUNG-CANCER - 10 YEARS EXPERIENCE OF THE EUROPEAN LUNG-CANCER WORKING PARTY, European journal of cancer, 33(14), 1997, pp. 2326-2332
Authors:
ROZENBERG S
KROLL M
VANDROMME J
PAESMANS M
LEFEVER A
HAM H
Citation: S. Rozenberg et al., FACTORS INFLUENCING THE PRESCRIPTION OF OSTEOPOROSIS THERAPY AMONG GYNECOLOGISTS, Journal of bone and mineral research, 12, 1997, pp. 526-526
Authors:
SCULIER JP
PAESMANS M
LIBERT P
BUREAU G
DABOUIS G
THIRIAUX J
MICHEL J
VANCUTSEM O
SCHMERBER J
GINER V
BERCHIER MC
MOMMEN P
SERGYSELS R
KLASTERSKY J
Citation: Jp. Sculier et al., THE PROGNOSTIC FACTORS FOR ADVANCED NONSM ALL CELL LUNG-CANCER - THE EXPERIENCE OF THE EUROPEAN LUNG-CANCER WORKING PARTY, Revue des maladies respiratoires, 14(6), 1997, pp. 445-449
Authors:
FELD R
ABRATT R
GRAZIANO S
JASSEM J
LACQUET L
NINANE V
PAESMANS M
ROCMANS P
SCHIEPERS C
STAHEL R
STEPHENS R
Citation: R. Feld et al., PRETREATMENT MINIMAL STAGING AND PROGNOSTIC FACTORS FOR NONSMALL CELLLUNG-CANCER, Lung cancer, 17, 1997, pp. 3-10
Authors:
ROZENBERG S
KROLL M
VANDROMME J
PAESMANS M
LEFEVER A
HAM H
Citation: S. Rozenberg et al., FACTORS INFLUENCING THE PRESCRIPTION OF HORMONE REPLACEMENT THERAPY, Obstetrics and gynecology, 90(3), 1997, pp. 387-391
Authors:
VEKEMANS M
DELVIGNE A
PAESMANS M
Citation: M. Vekemans et al., CONTINUATION RATES WITH A LEVONORGESTREL-RELEASING CONTRACEPTIVE IMPLANT (NORPLANT(R)) - A PROSPECTIVE-STUDY IN BELGIUM, Contraception, 56(5), 1997, pp. 291-299
Authors:
HANN I
VISCOLI C
PAESMANS M
GAYA H
GLAUSER M
Citation: I. Hann et al., A COMPARISON OF OUTCOME FROM FEBRILE NEUTROPENIC EPISODES IN CHILDRENCOMPARED WITH ADULTS - RESULTS FROM 4 EORTC STUDIES, British Journal of Haematology, 99(3), 1997, pp. 580-588
Authors:
MEURISSE M
CLAEYS N
PAESMANS M
DANG MN
DEGAUQUE C
DELMELLE M
LARSIMONT D
THOOFTANDRY M
VERHEST A
HAMOIR E
ANDRY G
SQUIFFLET JP
Citation: M. Meurisse et al., THE BELGIAN THYROID-CANCER STUDY-GROUP, P RELIMINARY EPIDEMIOLOGIC TRENDS REVEALED BY A RETROSPECTIVE ANALYSIS (1988-1995), Annales d'Endocrinologie, 58(3), 1997, pp. 163-171
Authors:
ERBIL P
RAZAVI D
FARVACQUES C
BILGE N
PAESMANS M
VANHOUTTE P
Citation: P. Erbil et al., CANCER-PATIENTS PSYCHOLOGICAL ADJUSTMENT AND PERCEPTION OF ILLNESS - CULTURAL-DIFFERENCES BETWEEN BELGIUM AND TURKEY, Supportive care in cancer, 4(6), 1996, pp. 455-461
Authors:
ROZENBERG S
KROLL M
VANDROMME J
HAM H
LEFEVER A
RIERA C
PAESMANS M
Citation: S. Rozenberg et al., PHYSICIANS ATTITUDE TOWARDS HORMONE REPLACEMENT THERAPY PRESCRIPTION FOR POSTMENOPAUSAL OSTEOPOROSIS PREVENTION, Journal of bone and mineral research, 11, 1996, pp. 639-639
Authors:
SCULIER JP
PAESMANS M
BUREAU G
GINER V
LECOMTE J
MICHEL J
BERCHIER MC
VANCUTSEM O
KUSTNER U
KROLL F
SERGYSELS R
MOMMEN P
KLASTERSKY J
Citation: Jp. Sculier et al., RANDOMIZED TRIAL COMPARING INDUCTION CHEMOTHERAPY VERSUS INDUCTION CHEMOTHERAPY FOLLOWED BY MAINTENANCE CHEMOTHERAPY IN SMALL-CELL LUNG-CANCER, Journal of clinical oncology, 14(8), 1996, pp. 2337-2344
Authors:
ROZENBERG S
KROLL M
VANDROMME J
PAESMANS M
HAM H
Citation: S. Rozenberg et al., EFFECT OF BONE-DENSITY EVALUATION ON HORMONE REPLACEMENT THERAPY PRESCRIPTION, Maturitas, 24(1-2), 1996, pp. 57-61
Authors:
BORGES M
SCULIER JP
PAESMANS M
RICHEZ M
BUREAU G
DABOUIS G
LECOMTE J
MICHEL J
VANCUTSEM O
SCHMERBER J
GINER V
BERCHIER MC
SERGYSELS R
MOMMEN P
KLASTERSKY J
Citation: M. Borges et al., PROGNOSTIC FACTORS FOR RESPONSE TO CHEMOTHERAPY CONTAINING PLATINUM DERIVATIVES IN PATIENTS WITH UNRESECTABLE NONSMALL CELL LUNG-CANCER (NSCLC), Lung cancer, 16(1), 1996, pp. 21-33